Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Bernstein analyst Stacy Rasgon downgraded Qualcomm Inc (NASDAQ:QCOM) from Outperform to Market Perform and cut the price target from $175 to $140. Qualcomm shares closed at $130.35 on Wednesday. See how other analysts view this stock.
- Citizens analyst Silvan Tuerkcan downgraded Terns Pharmaceuticals Inc (NASDAQ:TERN) from Market Outperform to Market Perform. Terns Pharma shares closed at $52.86 on Wednesday. See how other analysts view this stock.
- Cantor Fitzgerald analyst Kristen Kluska downgraded ADMA Biologics Inc (NASDAQ:ADMA) from Overweight to Neutral. ADMA Biologics shares closed at $9.63 on Wednesday. See how other analysts view this stock.
- TD Cowen analyst Ritu Baral downgraded Terns Pharmaceuticals Inc (NASDAQ:TERN) from Buy to Hold and announces $53 price target. Terns Pharma shares closed at $52.86 on Wednesday. See how other analysts view this stock.
Considering buying QCOM stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments